Clinical trial
Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial…
NCT00448435 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00448435 |
|---|---|
| Title | Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma |
| Official title | A Study to Compare GW815SF HFA MDI With Concomitant Treatment With Salmeterol Xinafoate DPI Plus Fluticasone Propionate DPI and to Assess Long-term Safety of GW815SF HFA MDI |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bronchial Asthma |
| Intervention type | Drug |
| Interventions | GW815SF HFA MDI, salmeterol and fluticasone propionate |
| Enrollment | 51 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Mar 16, 2007 |
| Last update posted | Jun 8, 2010 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: